Anthracyclines/pembrolizumabMyocarditis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70794-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：44 / 44

相关论文

共 50 条

[31] PembrolizumabMyocarditis: case report
Reactions Weekly, 2023, 1947 (1) : 330 - 330
[32] PembrolizumabMyocarditis: case report
Reactions Weekly, 2022, 1901 (1) : 397 - 397
[33] PembrolizumabMyocarditis: case report
Reactions Weekly, 2020, 1835 (1) : 317 - 317
[34] PembrolizumabMyocarditis: case report
Reactions Weekly, 2025, 2053 (1) : 304 - 304
[35] Anthracyclines/busulfan/posaconazoleTreatment failure following drug interaction and hyperbilirubinaemia: 2 case reports
Reactions Weekly, 2020, 1800 (1) : 39 - 39
[36] PembrolizumabMyocarditis and myositis: case report
Reactions Weekly, 2025, 2053 (1) : 303 - 303
[37] Anthracyclines/antineoplastics/dimethyl sulfoxideVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1809 (1) : 27 - 27
[38] PembrolizumabMyocarditis and hypothyroidism: case report
Reactions Weekly, 2023, 1949 (1) : 356 - 356
[39] PembrolizumabMyocarditis and myositis: case report
Reactions Weekly, 2020, 1798 (1) : 222 - 222
[40] PembrolizumabMyocarditis and enteritis: case report
Reactions Weekly, 2023, 1946 (1) : 458 - 458

← 1 2 3 4 5 →